Houston Holmes

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Javier Muñoz, André Goy et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text

Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

Michael Wang, Javier Muñoz, André Goy et al. · Journal of Clinical Oncology · 2022 · 283 citations · Full text

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

Bijal Shah, Michael R. Bishop, Olalekan O. Oluwole et al. · Blood · 2021 · 190 citations · Full text

Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advanced Myeloid Malignancies After Allogeneic Stem-Cell Transplantation

John E. Levine, Thomas Braun, Samuel L. Penza et al. · Journal of Clinical Oncology · 2002 · 169 citations

Cell Therapy, Immunology, Prospective Trial +21

Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures

Barbara A. Konkle, Kenneth A. Bauer, Robert S. Weinstein et al. · Transfusion · 2003 · 60 citations